Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/1996
10/24/1996WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection
10/24/1996WO1996032961A1 Compositions and methods for regulating hair growth
10/24/1996WO1996032951A1 Controlled release of miotic and mydriatic drugs in the anterior chamber
10/24/1996WO1996032946A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
10/24/1996WO1996032933A1 External preparations for treating dermatoses
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996WO1996017953A3 Genetic basis of factor xiii activity
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218679A1 Apopain
10/24/1996CA2217865A1 Efflux pump inhibitors
10/24/1996CA2193742A1 External preparations for treating dermatoses
10/23/1996EP0738512A1 Use of a HMG CoA reductase inhibitor to prevent a second heart attack
10/23/1996EP0738510A2 Use of an HMG-CoA reductase as anti-ageing agent
10/23/1996EP0738475A1 Alpha-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
10/23/1996EP0738149A1 1-aminoindan derivatives and compositions thereof
10/23/1996EP0738107A1 Inhibitors of fatty acid synthesis as antimicrobial agents
10/23/1996EP0593491B1 Luteinizing hormone releasing hormone antagonist peptides
10/23/1996EP0416094B1 Parathyroid hypertensive factor
10/23/1996CN1134110A Method for regulating gastrointestinal motility
10/23/1996CN1134107A Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
10/23/1996CN1133712A Use of 12, 24-dihydroxy vitamin D2
10/22/1996US5567859 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
10/22/1996US5567733 Mucous membrane
10/22/1996US5567731 Gaba-ergic modulation of eye growth
10/22/1996US5567724 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
10/22/1996US5567696 Treatment of systemic lupus erythematosus with dehydroepiandrosterone
10/22/1996US5567689 Methods for increasing uridine levels with L-nucleosides
10/22/1996US5567686 Method for protection against genotoxic mutagenesis
10/22/1996US5567592 Identifying compounds useful for increasing bioavailability of drug in mammal
10/21/1996CA2174602A1 .alpha.-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
10/20/1996CA2172884A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032143A1 Coating for bio-material insertable into the bloodstream or tissue of the human body
10/17/1996WO1996032133A2 Conjugate for treating inflammatory, infectious and/or skin diseases
10/17/1996WO1996032120A1 Anionic oxygen radicals containing therapeutic agents and their use in pain relief
10/17/1996WO1996032115A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996WO1996032108A1 Treatment for ocular inflammation
10/17/1996WO1996032107A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
10/17/1996WO1996032104A1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
10/17/1996WO1996028185A3 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor
10/17/1996DE19514088A1 Konjugat zur Behandlung von Entzünduns-, Infektions- und/oder Hauterkrankungen A conjugate for the treatment of Entzünduns-, infectious and / or skin diseases
10/17/1996CA2218103A1 Coating for biomaterial which can be introduced into the bloodstream or into the tissue of the human body
10/17/1996CA2217951A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996CA2217599A1 Treatment for ocular inflammation
10/17/1996CA2216858A1 Phospholipase c homolog
10/16/1996EP0737926A1 Method for determining pharmacodynamic parameters and designing a dosing regimen for a drug
10/16/1996EP0737473A1 Effervescent dosage form
10/16/1996EP0737196A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
10/16/1996EP0737069A1 Deuterised active agents in transdermal application
10/16/1996EP0737067A1 Method of treatment of hormone-unresponsive metastatic prostate cancer
10/16/1996EP0524989B1 Controlled release drug formulation
10/16/1996CN1133173A Preparation of diuretic by using neuropsychic tension antagonist
10/15/1996US5565487 Method of treating wrinkles using galactonic acid or galactonolactone
10/15/1996US5565466 Methods for modulating the human sexual response
10/15/1996US5565454 Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
10/15/1996US5565418 Retroviral protease inhibiting compounds
10/15/1996US5565351 Reducing the muscle protein loss by reducing proteolysis
10/12/1996CA2173821A1 Method for determining pharmacodynamic parameters and designing a dosing regimen for a drug
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031239A1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent
10/10/1996WO1996031238A1 Agent for circulatory organs
10/10/1996WO1996031237A2 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
10/10/1996WO1996031218A1 Pharmaceutical composition containing sucralfate
10/10/1996WO1996031217A1 Inhibiting retroviral replication
10/10/1996WO1996031213A1 Pharmaceutical composition containing proton pump inhibitors
10/10/1996WO1996031212A1 A method for the treatment of macular degeneration
10/10/1996WO1996021416A3 Methods and compositions for treatment of solid tumors in vivo
10/10/1996WO1996001430A3 Screening for nuc inhibitors
10/10/1996CA2217233A1 Sucralfate containing pharmaceutical composition
10/10/1996CA2216281A1 A method for the treatment of macular degeneration
10/10/1996CA2215978A1 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
10/09/1996EP0736002A1 Compound capable of introducing at least one molecule into a cell
10/09/1996EP0735895A1 A method for preventing or controlling cataract
10/09/1996EP0735890A1 Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
10/09/1996EP0735888A1 Purine compositions and methods for administration
10/09/1996EP0735881A1 Means and method for hormonal contraception and/or the treatment of acne
10/09/1996EP0735877A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
10/09/1996EP0735870A1 Use of pla 2? inhibitors as treatment for alzheimer's disease
10/09/1996EP0735868A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
10/09/1996EP0735863A1 Accelerated release composition containing bromocriptine
10/09/1996EP0735819A1 New cryptophycins
10/09/1996EP0354921B1 Use of melatonin for the manufacture of a contraceptive composition
10/09/1996CN1133050A Composition and methods using nitroxides to avoid oxygen toxicity
10/09/1996CN1132625A NK-1 receptor antagonits and 5HT3 receptor antagonists for treatment of emesis
10/08/1996US5563164 Treating arthritis, psoriasis, asthma, inflammatory bowel disease, or alzheimer's disease
10/08/1996US5563146 Administering rapamycin
10/08/1996US5563132 Two-step cancer treatment method
10/08/1996US5562910 Vaccine compositions and method for enhancing an immune response
10/08/1996US5562904 Retroviral transduction of cells using soluble complement inhibitors
10/03/1996WO1996030762A1 Insulin mimetic and enhancer assay
10/03/1996WO1996030544A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa
10/03/1996WO1996030535A1 Gene transfer into the kidney
10/03/1996WO1996030505A1 Methods for screening compounds for estrogenic activity
10/03/1996WO1996030046A1 Vascular endothelial cell growth factor antagonists
10/03/1996WO1996030036A1 Compounds and compositions for delivering active agents
10/03/1996WO1996030023A1 19-oxygenated steroids as therapeutic agents
10/03/1996WO1996030009A2 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid
10/03/1996WO1996029999A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
10/03/1996WO1996029997A1 Soft gelatin capsule with a gelatin shell comprising xanthine derivative
10/03/1996WO1996029987A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors
1 ... 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 ... 1151